Marc Semigran, Chief Development Officer at Edgewise Therapeutics, Inc. (EWTX), sold 59,418 shares at $29.66 ($1.8M) on 2024-12-24, disclosed to the SEC on 2024-12-27.
Scheduled sale ($1.8M) by Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.66 | 27,980 | $830K | 47.1% |
| 2 | $29.66 | 27,980 | $830K | 47.1% |
| 3 | $30.08 | 1,729 | $52K | 2.9% |
| 4 | $30.08 | 1,729 | $52K | 2.9% |
| Total | $29.68 avg | 59,418 | $1.8M | 100% |